Prelude Therapeutics Incorporated
PRLD
$1.00
$0.117313.29%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 99.07M | 133.61M | 153.63M | 179.84M | 201.92M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.33M | 2.28M | 2.76M | 2.87M | 3.44M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 102.40M | 135.90M | 156.39M | 182.71M | 205.37M |
|
|
|||||
| Total Current Assets | 102.40M | 135.90M | 156.39M | 182.71M | 205.37M |
| Net Property, Plant & Equipment | 34.70M | 35.47M | 36.38M | 37.13M | 37.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.15M | 4.15M | 4.45M | 4.45M | 4.34M |
| Total Assets | 141.26M | 175.52M | 197.22M | 224.29M | 247.11M |
|
|
|||||
| Total Accounts Payable | 5.83M | 7.73M | 5.92M | 6.17M | 5.31M |
| Total Accrued Expenses | 10.61M | 14.44M | 12.78M | 10.97M | 9.35M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.65M | 2.70M | 2.72M | 2.74M | 2.19M |
| Total Finance Division Other Current Liabilities | 696.00K | 771.00K | 801.00K | 3.46M | 800.00K |
| Total Other Current Liabilities | 696.00K | 771.00K | 801.00K | 3.46M | 800.00K |
| Total Current Liabilities | 19.79M | 25.64M | 22.22M | 23.34M | 17.64M |
|
|
|||||
| Total Current Liabilities | 19.79M | 25.64M | 22.22M | 23.34M | 17.64M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.27M | 15.33M | 15.41M | 15.47M | 15.45M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.03M | 3.09M | 3.15M | 3.22M | 3.28M |
| Total Liabilities | 38.08M | 44.06M | 40.79M | 42.02M | 36.37M |
|
|
|||||
| Common Stock & APIC | 718.81M | 714.99M | 711.10M | 705.13M | 698.79M |
| Retained Earnings | -615.65M | -583.56M | -554.83M | -522.56M | -487.82M |
| Treasury Stock & Other | 12.00K | 35.00K | 167.00K | -290.00K | -235.00K |
| Total Common Equity | 103.18M | 131.46M | 156.43M | 182.28M | 210.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 103.18M | 131.46M | 156.43M | 182.28M | 210.73M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 103.18M | 131.46M | 156.43M | 182.28M | 210.73M |
|
|
|||||